Voluntary nationwide recall: Potassium (Glenmark – June)
Glenmark Pharmaceuticals Inc. is recalling 114 batches of Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K. Potassium Chloride is used for the treatment of low potassium.
This drug is being recalled because the product failed to dissolve in the body. This may cause high potassium levels, which can result in irregular heartbeat that can lead to cardiac arrest.
As of the date of Glenmark’s recall announcement, June 24, 2024, there have been no reports of adverse events related to this recall. Consult your health care provider before you stop using this product. To see if your medication was recalled, contact your doctor or pharmacy where you received the medication or visit the FDA website below.
To learn more about this recall, you can take one or more of the steps below.
- Talk to your doctor or pharmacist.
- Call Inmar Rx Solutions at 1-877-883-9273. TTY users should call 711. Help is available Monday through Friday from 9 a.m. to 5 p.m. EST.
- Visit the FDA website.